Search results for "Bran"

showing 10 items of 6477 documents

Innovative technologies for food preservation

2018

Abstract Several techniques have been developed during the 20th century in order to preserve foods. These innovative technologies vary considerably and embrace physical technologies (e.g., high hydrostatic pressure and high-pressure homogenization), electromagnetic technologies (e.g., pulsed electric fields, ohmic heating, microwaves, radio-frequency, and UV-light), acoustic technologies (e.g., ultrasound and shockwaves), and others such as membrane filtration and dense phase CO 2 . In this chapter, the theoretical background and definition of the technologies are explained together with a description of the equipment, main technological/processing parameters, and some advantages and limita…

0301 basic medicineOther Engineering and Technologies030109 nutrition & dieteticsMaterials sciencebusiness.industryHydrostatic pressureMechanical engineeringHigh-pressure homogenization04 agricultural and veterinary sciences040401 food scienceElectromagnetic03 medical and health sciences0404 agricultural biotechnologyHigh pressure homogenizationHigh hydrostatic pressureOhmic heatingUltrasoundDense phaseEngineering and TechnologyProcess engineeringbusinessPulsed electric fieldsMicrowavesMembrane filtration
researchProduct

Vital dyes in macular hole surgery

2021

Currently, surgical techniques, such as internal limiting membrane peeling, are used widely for macular holes, macular puckers, epiretinal membranes, diabetic macular edema, retinal detachment, retinal vein occlusions, vitreomacular traction, optic pit maculopathy, and Terson syndrome. This study aimed to highlight any differences regarding visual acuity and ocular tomography coherence changes after staining the internal limiting membrane with dilutions of Brilliant Blue G vs. lutein/zeaxanthin-based dyes. This study involved 30 eyes of 30 patients who had undergone posterior pole vitrectomy for idiopathic stage 4 macular hole. The study lot was divided in two subgroups, 15 eyes colored wit…

0301 basic medicinePars planaCancer Researchmedicine.medical_specialtyVisual acuityinternal limiting membranegenetic structuresmedicine.medical_treatmentlutein and zeaxanthin dyesVitrectomyVitreomacular traction03 medical and health sciences0302 clinical medicineImmunology and Microbiology (miscellaneous)intraocular dyesOptic pitmedicinestaining techniqueMacular holepars plana vitrectomybusiness.industryBrilliant Blue GcromovitrectomyRetinal detachmentGeneral MedicineArticlesmedicine.diseaseeye diseasesSurgerymacular hole030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisMaculopathysense organsmedicine.symptombusinessExperimental and Therapeutic Medicine
researchProduct

Modified Vitrectomy Technique for Phakic Rhegmatogenous Retinal Detachment with Intermediate Break

2018

Purpose. To evaluate the effects of a modification of the traditional 25-gauge pars plana vitrectomy technique in the treatment of uncomplicated macula-on rhegmatogenous retinal detachment (RRD) with intermediate retinal break(s) and marked vitreous traction in the phakic eye. Methods. Prospective, noncomparative, and interventional case series. All consecutive phakic eyes with primary uncomplicated macula-on RRD with intermediate retinal break(s) and marked vitreous traction, with at least 1 year of postoperative follow-up, were enrolled. In all eyes, “localized 25-gauge vitrectomy” under air infusion with localized removal of the vitreous surrounding the retinal break(s), in association w…

0301 basic medicinePars planamedicine.medical_specialtygenetic structuresArticle Subjectmedicine.medical_treatmentScheimpflug principlevitrectomyVitrectomy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:OphthalmologyOphthalmologymedicineMacular edemabusiness.industryRetinal detachmentRetinalmedicine.diseaseeye diseasesOphthalmology030104 developmental biologymedicine.anatomical_structurechemistrylcsh:RE1-994030221 ophthalmology & optometryClinical StudyTamponadesense organsEpiretinal membranebusiness
researchProduct

Intracellular fluoride influences TASK mediated currents in human T cells.

2019

The expression of Kv1.3 and KCa channels in human T cells is essential for maintaining cell activation, proliferation and migration during an inflammatory response. Recently, an additional residual current, sensitive to anandamide and A293, compounds specifically inhibiting currents mediated by TASK channels, was observed after complete pharmacological blockade of Kv1.3 and KCa channels. This finding was not consistently observed throughout different studies and, an in-depth review of the different recording conditions used for the electrophysiological analysis of K+ currents in T cells revealed fluoride as major anionic component of the pipette intracellular solutions in the initial studie…

0301 basic medicinePatch-Clamp TechniquesTime FactorsPotassium CompoundsT-LymphocytesImmunologyMagnesium ChlorideMembrane Potentials03 medical and health scienceschemistry.chemical_compoundFluorides0302 clinical medicinePotassium Channels Tandem Pore DomainPotassium Channel BlockersImmunology and AllergyHumansCells CulturedKv1.3 Potassium ChannelActivator (genetics)ChemistryPipetteAnandamideElectrophysiology030104 developmental biologyMembraneBiophysicsCell activationFluorideIntracellular030215 immunologyJournal of immunological methods
researchProduct

Mesopolysaccharides: The extracellular surface layer of visceral organs

2020

The mesothelium is a dynamic and specialized tissue layer that covers the somatic cavities (pleural, peritoneal, and pericardial) as well as the surface of the visceral organs such as the lung, heart, liver, bowel and tunica vaginalis testis. The potential therapeutic manipulation of visceral organs has been complicated by the carbohydrate surface layer—here, called the mesopolysaccharide (MPS)—that coats the outer layer of the mesothelium. The traditional understanding of MPS structure has relied upon fixation techniques known to degrade carbohydrates. The recent development of carbohydrate-preserving fixation for high resolution imaging techniques has provided an opportunity to re-examine…

0301 basic medicinePathologyRespiratory Systemlcsh:MedicineBiochemistryEpitheliumMice0302 clinical medicineLectinsMedicine and Health SciencesElectron Microscopylcsh:ScienceLungFixation (histology)MicroscopyMultidisciplinaryMembrane GlycoproteinsMicrovilliOrganic CompoundsChemistryQRThoraxExtracellular MatrixChemistrymedicine.anatomical_structureLiverTransmission electron microscopy030220 oncology & carcinogenesisPhysical SciencesPleuraeMedicineCellular Structures and OrganellesAnatomyResearch ArticleChemical Elementsmedicine.medical_specialtyScienceCarbohydratesResearch and Analysis MethodsRuthenium03 medical and health sciencesMicroscopy Electron TransmissionPolysaccharidesmedicineExtracellularAnimalsSurface layerProcess (anatomy)LungMyocardiumOrganic Chemistrylcsh:RChemical CompoundsBiology and Life SciencesProteinsCell BiologyMesothelium030104 developmental biologyMurine lungTransmission Electron Microscopylcsh:QLungsPLoS ONE
researchProduct

Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis

2016

Background: Breakdown of extracellular matrix (ECM) is one of the important hallmarks of cancer progression which facilitates the invasion of tumoral cells to the surrounding tissue. Matrix metalloproteinases (MMPs) can degrade various components of the ECM and basement membrane. The aim of this study was to determine the role of matrix metalloproteinases-9 protein in the biologic behavior of oral squamous cell carcinoma (OSCC) and its relation with tumor angiogenesis. Material and Methods: In this study 42 OSCC and 15 normal epithelium were reviewed by immunohistochemical staining for matrix metalloproteinases-9 and CD105. Results: Matrix metalloproteinases-9 expression was detected in 32 …

0301 basic medicinePathologymedicine.medical_specialtyAngiogenesisOdontologíaMatrix metalloproteinaseMMP9Extracellular matrix03 medical and health sciences0302 clinical medicinemedicineGeneral DentistryBasement membraneOral Medicine and Pathologybusiness.industryResearchCancerEndoglin:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la salud030104 developmental biologymedicine.anatomical_structureTumor progression030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbusinessJournal of Clinical and Experimental Dentistry
researchProduct

Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psori…

2016

Objective To investigate the expression and tissue distribution of Th9-related cytokines in patients with psoriatic arthritis (PsA). Methods Quantitative gene expression analysis of Th1, Th17, and Th9 cytokines was performed in intestinal biopsy samples obtained from patients with PsA, HLA-B27-positive patients with ankylosing spondylitis (AS), patients with Crohn's disease (CD), and healthy controls. Expression and tissue distribution of interleukin-23 (IL-23), IL-17, IL-22, IL-9, and IL-9 receptor (IL-9R) were evaluated by immunohistochemistry and confocal microscopy. Flow cytometry was used to study the frequency of Th9 cells among peripheral blood, lamina propria, and synovial fluid mon…

0301 basic medicinePathologymedicine.medical_specialtyImmunologyHigh endothelial venulesArthritisInflammationPeripheral blood mononuclear cell03 medical and health sciences0302 clinical medicineRheumatologymedicineImmunology and AllergyInterleukin 9030203 arthritis & rheumatologyLamina propriabusiness.industrymedicine.disease3. Good health030104 developmental biologymedicine.anatomical_structureImmunologyPaneth cellmedicine.symptomSynovial membranebusinessArthritis & Rheumatology
researchProduct

(+)-Pentazocine reduces oxidative stress and apoptosis in microglia following hypoxia/reoxygenation injury

2016

Abstract Background Sigma-1 receptors (σ 1 R) are highly expressed in neurons as well as microglia and have been shown to modulate the inflammatory response in the central nervous system and thus may serve as possible target for neuroprotective strategies. The aim of the present study was to test the effect of (+)-pentazocine, a putative σ 1 R agonist, in an in vitro model of microglia activation. Methods Microglia (BV2 cells) was exposed (3 h) to 1% oxygen and reoxygenation was allowed for 24 h. Cells were treated with different concentrations (1, 10, 25 and 50 μM) of (+)-pentazocine in the presence or absence of NE-100 (1 μM), a well established σ 1 R antagonist. Cell viability and apopto…

0301 basic medicinePentazocineSigma receptorCell SurvivalmicrogliaApoptosisPharmacologyBiologymedicine.disease_causeNeuroprotection(+)-PentazocineCell LineMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePentazocine; microglia; SIGMAmedicineAnimalsReceptors sigmaViability assayAnnexin A5PhosphorylationHypoxiaMembrane Potential MitochondrialMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MicrogliaAnimalGeneral NeuroscienceApoptosiOxidative StreGlutathioneGlutathioneOxidative Stress030104 developmental biologymedicine.anatomical_structurePentazocineBiochemistrychemistryApoptosis030217 neurology & neurosurgeryIntracellularOxidative stressSIGMAmedicine.drug
researchProduct

Cytotoxicity and mode of action of a naturally occurring naphthoquinone, 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone towards multi-factorial dr…

2017

Abstract Introduction Malignacies are still a major public concern worldwide and despite the intensive search of new chemotherapeutic agents, treatment still remains a challenging issue. The present study was designed to evaluate the cytotoxicity of 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone (AMNQ) isolated from the bark of Milletia versicolor towards a panel of drug-sensitive and multidrug-resistant (MDR) cancer cell lines. Methods The resazurin reduction assay was used to evaluate the cytotoxicity of AMNQ against 9 drug-sensitive and multidrug-resistant (MDR) cancer cell lines. Cell cycle, mitochondrial membrane potential (MMP) and levels of reactive oxygen species were all analyze…

0301 basic medicinePharmaceutical ScienceApoptosisPharmacologyFlow cytometry03 medical and health sciences0302 clinical medicineCell Line TumorDrug DiscoverymedicineHumansCytotoxic T cellCytotoxicityMembrane Potential MitochondrialPharmacologymedicine.diagnostic_testPlant ExtractsChemistryCell CycleCancerCell cyclemedicine.diseaseAntineoplastic Agents PhytogenicDrug Resistance MultipleMultiple drug resistance030104 developmental biologyComplementary and alternative medicineDoxorubicinDrug Resistance NeoplasmApoptosisCaspases030220 oncology & carcinogenesisCancer cellCancer researchMolecular MedicineReactive Oxygen SpeciesNaphthoquinonesPhytomedicine
researchProduct

Small endogenous molecules as moiety to improve targeting of CNS drugs.

2016

A major challenge in the development of novel neuro-therapeutic agents is to effectively overcome the blood-brain barrier (BBB), which acts as a 'working dynamic barrier'. The core problem in the treatment of neurodegenerative diseases is failed delivery of potential medicines due to their inadequate permeation rate. Areas covered: The present review gives a summary of endogenous moieties used in synthesizing prodrugs, derivatives and bioisosteric drugs appositely designed to structurally resemble physiological molecular entities able to be passively absorbed or carried by specific carrier proteins expressed at BBB level. In particular, this overview focuses on aminoacidic, glycosyl, purine…

0301 basic medicinePharmaceutical ScienceEndogenyComputational biologyPharmacologyBlood–brain barrierDiffusion03 medical and health sciences0302 clinical medicinemedicinesmall endogenous moleculesMoietyCNS prodrugAnimalsHumansProdrugsmultifunctional drugbiologyMembrane transport proteinChemistryCNS carrierMembrane Transport ProteinsTranslation (biology)TransporterBiological TransportProdrug030104 developmental biologymedicine.anatomical_structurebioisosteric drugCarrier proteinSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBlood-Brain Barrierbiology.proteinCarrier ProteinsBBB030217 neurology & neurosurgeryCentral Nervous System AgentsExpert opinion on drug delivery
researchProduct